OptiScan Biomedical
Hayward
About OptiScan Biomedical
OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $165.0M
- Funding stage: Late Stage Venture
- Last round: Series E (Mar 2019)
- Website: optiscancorp.com
- Phone: (510)342-5800
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/optiscan-biomedical-129592 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.